Navigation Links
Medisafe 1 Technologies to Start the $1MM Stock Repurchase Program of 10MM Shares up to 10 Cents a Share
Date:2/14/2012

JERUSALEM, Israel, February 13, 2012 /PRNewswire/ --

Medisafe 1 Technologies Corp. (OTCBB: MFTH), a developer of patented technologies that physically prevent unauthorized administration of prescription medications, announced today that the company plans to start the implementation of the share buyback at the beginning of the forthcoming month of March 2012

Under the program approved by the BOD, Medisafe 1 Technologies is authorized to repurchase up to 10 million of its outstanding shares of common stock during the next 12 months at a price up to $0.10 per share on the open market or by conducting privately negotiated transactions depending on current market conditions and other factors.

"Medisafe 1 Technologies continues to progress in our efforts to bring further added value to our shareholders," said Jacob Elhadad, CEO of Medisafe 1 Technologies Corp. "The repurchase of shares will enable us to acquire additional technologies that augment our existing commercial product line and we will updating our shareholders in the forthcoming weeks of new and exciting news in regards to further acquisitions."

About Medisafe 1 Technologies

Medisafe 1 Technologies seeks to effectively prevent unauthorized administration of a drug or medicinal substance by hypodermic needle. Medisafe's patented technology is a medical assembly with a locking mechanism that is intended to ensure the substance cannot be released from the hypodermic needle without positive pre-matching between the substance and its intended patient.

Forward-Looking Statements

This letter contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 as amended and Section 21E of the Securities Exchange Act of 1934 as amended. All forward-looking statements are inherently uncertain, based on current expectations and assumptions concerning future events or future performance of Medisafe 1 Technologies Corp., and its technologies. In evaluating such statements, prospective investors should review carefully various risks and uncertainties identified in this release, as actual results may differ materially from those indicated. Medisafe 1 Technologies Corp. public filings may be viewed at http://www.sec.gov.

Contact: Jacob Elhadad CEO +972-524440000 Jacob.elhadad10@gmail.com



'/>"/>
SOURCE Medisafe 1 Technologies Corp.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. The Israeli Governments Ministry of Health Invites Medisafe 1 Technologies to Demonstrate its Unique Syringe Locking Device Technology
2. Medisafe 1 Technologies Announces 1-5 Stock Dividend
3. Spherix to Present at the LHA Life Sciences & Medical Technologies Virtual Conference on February 16
4. BioStorage Technologies to Host Global Sample Management Workshop at Partnerships in Clinical Trials
5. UV Flu Technologies Continues Aggressive Program to Pay off Convertible Debt
6. Generex Announces Patent Award for its Core Vaccine Technologies in Japan
7. FirstMark to Exhibit at Cardiovascular Research Technologies (CRT) 2012 Conference
8. Cell Therapy - Technologies, Markets and Companies
9. Life Technologies to Present at Upcoming Investment Conferences in February
10. Life Technologies Partners With DaAn Gene to Develop and Commercialize Molecular Diagnostic Assays in China
11. Life Technologies Announces Redemption of 1.5% Convertible Senior Notes Due 2024
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/8/2019)... ... 2019 , ... As Keck Graduate Institute (KGI) students completing ... with a set of recommendations to enhance supply chain processes. Now the 2019 ... to a wider audience of industry leaders attending the 12th Annual Bio Supply ...
(Date:10/3/2019)... Calif. (PRWEB) , ... October 02, 2019 , ... ... a new life sciences leadership firm that is enabling clinical program outsourcing success ... , Founded by award-winning pharma and biotech veteran executive Brenda Reese, phaseUP™ brings ...
(Date:9/30/2019)... ... September 30, 2019 , ... The September 2019 edition ... , is now available online on the company’s global website. The Bridge features ... diffraction, fluorescence and imaging, and presents articles, scientific papers and news reports. ...
(Date:9/24/2019)... ... , ... The Grain Foods Foundation is excited to announce ... Holscher is an Assistant Professor of Nutrition in the Department of Food Science ... Illinois Urbana-Champaign, where she has affiliate appointments with the Institute of Genomic Biology ...
Breaking Biology Technology:
(Date:9/25/2019)... ... September 25, 2019 , ... ... have placed over 20,000 dental implants for a variety of procedures, including single ... and pterygoid dental implants. Dental implants offer patients permanent tooth replacement ...
(Date:9/24/2019)... ... September 23, 2019 , ... Global ... announce today that Holotype HLA and other Omixon products will be featured among ... American Society for Histocompatibility and Immunogenetics (ASHI) in Pittsburgh, PA. Omixon’s Lunch ...
(Date:9/22/2019)... ANGELES (PRWEB) , ... September 20, 2019 , ... ... that instrument makers are adjusting to client demands for precision medicine products. The ... with demand exceeding $19 billion in 2018, the pharma/bio sector is the largest ...
Breaking Biology News(10 mins):